미용성형 수술 시장 보고서 : 시술별, 성별, 연령대별, 최종사용자별, 지역별(2025-2033년)

The global cosmetic surgery market size reached USD 88.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 204.9 Billion by 2033, exhibiting a growth rate (CAGR) of 9.23% during 2025-2033. The increasing prevalence of skin-related diseases, rising awareness among individuals about new procedures, and the advent of smart implants represent some of the key factors driving the market.

Cosmetic surgery, also known as aesthetic surgery, is performed to enhance or change the appearance of a person. It comprises various surgical and non-invasive procedures that aid in improving the physical appearance, enhancing self esteem and confidence, correcting physical deformities or asymmetries, and improving the look of scars or other skin imperfections among individuals. At present, the expanding cosmetic and medical tourism, rising investments in improving healthcare infrastructure, and the development of high-quality healthcare services in several countries are catalyzing the demand for these surgeries across the globe.

Cosmetic Surgery Market Trends:

The increasing focus of individuals on improving their physical appearance, along with the rising influence of social media platforms, currently represents one of the major factors driving the demand for cosmetic surgeries around the world. Moreover, the surging prevalence of skin-related diseases, such as acne vulgaris, on account of sedentary lifestyles, unhealthy dietary patterns, hormonal imbalance and insomnia is favoring the market growth. In addition, there is an increase in the prevalence of obesity and other diseases that lead to excess fat accumulation in the body. This, in confluence with the growing global aging population, which is prone to develop sagging and loose skin, is influencing the market positively. Apart from this, governing agencies of numerous countries are undertaking measures to improve the safety of cosmetic procedures and generate awareness among individuals about new and advanced cosmetic procedures. Furthermore, there is an increase in the demand for minimally invasive (MI) surgical procedures around the world. Besides this, there is a rise in the integration of 3D printing, augmented reality (AR), virtual reality (VR), and artificial intelligence (AI) in cosmetic surgeries to create precise surgical guides, prosthetics, and implants and improve the accuracy and outcomes of procedures. These advanced technologies also help analyze data and images to optimize surgical planning, improve patient outcomes, and reduce human error. This, coupled with the advent of smart implants that help monitor and adapt to changes in the body, communicate with other devices like smartphones and provide real time data on the condition of the patient, is strengthening the growth of the market.

Key Market Segmentation:

Procedure Insights:

• Surgical Procedures
• Breast Augmentation
• Liposuction
• Eyelid Surgery
• Abdominoplasty
• Rhinoplasty
• Others
• Non-Surgical Procedures
• Botulinum Toxin
• Hyaluronic Acid
• Hair Removal
• Nonsurgical Fat Reduction
• Photo Rejuvenation
• Others

Gender Insights:

• Female
• Male

Age Group Insights:

• 13 To 29
• 30 To 54
• 55 and Above

End User Insights:

• Ambulatory Surgical Facility
• Hospitals and Clinics
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cosmetic surgery. Some of the factors driving the North America cosmetic surgery market included the growing demand for minimally invasive procedures, increasing adoption of cosmetic surgeries among older adultes, and the availability of advanced technologies.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global tea market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered AbbVie Inc., Alma Laser [Shanghai Fosun Pharmaceutical (Group) Co. Ltd], Cutera Inc., Cynosure LLC, Genesis Biosystems Inc., Long Island Plastic Surgical Group PC, Lumenis Inc (Boston Scientific Corporation), Sientra Inc., Sinclair Pharmaceuticals Limited, Solta Medical (Bausch Health Companies Inc.), Syneron Candela, Teoxane Laboratories, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. How big is the global cosmetic surgery market?
• 2. What is the expected growth rate of the global cosmetic surgery market during 2025-2033?
• 3. What are the key factors driving the global cosmetic surgery market?
• 4. What has been the impact of COVID-19 on the global cosmetic surgery market?
• 5. What is the breakup of the global cosmetic surgery market based on the procedure?
• 6. What is the breakup of the global cosmetic surgery market based on the gender?
• 7. What is the breakup of the global cosmetic surgery market based on the age group?
• 8. What is the breakup of the global cosmetic surgery market based on the end user?
• 9. What are the key regions in the global cosmetic surgery market?
• 10. Who are the key players/companies in the global cosmetic surgery market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cosmetic Surgery Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Procedure

• 6.1 Surgical Procedures
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Breast Augmentation
    • 6.1.2.2 Liposuction
    • 6.1.2.3 Eyelid Surgery
    • 6.1.2.4 Abdominoplasty
    • 6.1.2.5 Rhinoplasty
    • 6.1.2.6 Others
  • 6.1.3 Market Forecast
• 6.2 Non-Surgical Procedures
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Botulinum Toxin
    • 6.2.2.2 Hyaluronic Acid
    • 6.2.2.3 Hair Removal
    • 6.2.2.4 Nonsurgical Fat Reduction
    • 6.2.2.5 Photo Rejuvenation
    • 6.2.2.6 Others
  • 6.2.3 Market Forecast

7 Market Breakup by Gender

• 7.1 Female
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Male
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Age Group

• 8.1 13 To 29
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 30 To 54
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 55 and Above
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Ambulatory Surgical Facility
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Hospitals and Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

• 11.1 Overview
• 11.2 Drivers
• 11.3 Restraints
• 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 AbbVie Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Alma Laser (Shanghai Fosun Pharmaceutical(Group)Co. Ltd)
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Cutera Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
  • 15.3.4 Cynosure LLC
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Genesis Biosystems Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Long Island Plastic Surgical Group PC
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Lumenis Inc (Boston Scientific Corporation)
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Sientra Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
  • 15.3.9 Sinclair Pharmaceuticals Limited
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Solta Medical (Bausch Health Companies Inc.)
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Syneron Candela
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Teoxane Laboratories
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.